IM Cannabis expects accelerated growth in Germany

IM Cannabis is welcoming the German government’s final approval legalizing cannabis last Friday, as well as the landmark medical cannabis act that has the potential to facilitate access for many new patients as of April 1st. “We have been working toward this moment for the last 4 years,” said Richard Balla, CEO of IMC Germany. “We have the entire infrastructure in house. We are EU-GMP certified to repack bulk. We have an EU-GDP certified logistics center to store cannabis and are delivering IMC Cannabis to any pharmacy in Germany within 24 hours. Our team has extensive cannabis as well as pharmaceutical experience. We have all the necessary supply agreements in place to support accelerated growth. We believe that we are well positioned and are looking forward to growing significantly as the German market evolves as a result of the new legislation,” concluded Balla.